International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease
Arthritis Care & Research · 2026
DOI: 10.1002/acr.25623 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Arthritis Care & Research, 2026. Verfasst von Kristofer Andréasson und 15 weiteren Autor:innen. Beteiligte Einrichtung: Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lung Diseases, Interstitial, Gastrointestinal Microbiome, Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Boehringer Ingelheim, NHLBI NIH HHS, Ulla och Roland Gustafssons Donationsfond, Alfred Österlunds Stiftelse and Anna-Greta Crafoords Stiftelse.
Abstract (Originalsprache)
Objective
Mounting evidence supports an association between the intestinal microbiota and diverse pulmonary pathologies (ie, gut‐lung axis). Although intestinal dysbiosis is a feature of systemic sclerosis (SSc), no prior studies have investigated the relationship between intestinal microbiota and SSc‐associated interstitial lung disease (ILD) in a multinational cohort. This study aimed to characterize the intestinal microbiota of SSc‐ILD and determine whether specific bacterial species and functional pathways are associated with ILD severity.
Methods
Patients with SSc with and without ILD from seven SSc Centers across five continents provided a stool sample. Shotgun metagenomic sequencing was performed using the Illumina NovaSeq 6000 to characterize microbial composition at the species level. Quantitative image analysis of high‐resolution computed tomography scans of the chest was used to measure radiologic extent of ILD (QILD). Multivariate sparse partial least squares analyses were employed to identify a species signature of ILD and to determine whether specific species and functional pathways are associated with QILD.
Results
Among 285 participants (mean disease duration of 9.8 years), 62.5% had ILD. In a multivariate analysis of all participants, patients with ILD had a unique microbial signature compared to those without ILD characterized by increased abundance of candidate pathobiont species. In a subgroup of participants with SSc‐ILD (n = 103), specific bacterial species and functional pathways were associated with QILD.
Conclusion
This multicenter study demonstrates that distinct intestinal bacterial species are linked to the presence and radiologic extent of ILD in SSc. These species and/or their metabolic products may influence ILD pathogenesis and represent novel treatment targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lund University, Lund, Sweden.
- University of California, Los Angeles.
- Singapore General Hospital, SingHealth Duke-National University of Singapore Academic Medical Centre, Singapore.
- Ghent University, Ghent, Belgium.
- The University of Texas Health Science Center at Houston.
- Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Kristofer Andréasson, Antonia Valenzuela, Grace Hyun Kim, Elizabeth R Volkmann
Förderung
- Boehringer Ingelheim
- NHLBI NIH HHS
- Ulla och Roland Gustafssons Donationsfond, Alfred Österlunds Stiftelse and Anna-Greta Crafoords Stiftelse
- Anonymous Patient Donation
- National Heart, Lung, and Blood Institute
Zitieren
APA
Andréasson, K., Young, A., Joshi, S., Labus, J. S., Low, A. H. L., Smith, V., McMahan, Z., Proudman, S., Valenzuela, A., Hunter, P., Kim, G. H., Bozovic, G., Goldin, J., Aja, E., Jacobs, J. P., & Volkmann, E. R. (2026). International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease. Arthritis Care & Research. https://doi.org/10.1002/acr.25623
Vancouver
Andréasson K, Young A, Joshi S, Labus JS, Low AHL, Smith V, et al. International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease. Arthritis Care & Research. 2026. doi:10.1002/acr.25623
BibTeX
@article{Andrasson2026,
author = {Andréasson, Kristofer and Young, Arissa and Joshi, Swapna and Labus, Jennifer S and Low, Andrea Hsiu Ling and Smith, Vanessa and McMahan, Zsuzsanna and Proudman, Susanna and Valenzuela, Antonia and Hunter, Phoebe and Kim, Grace Hyun and Bozovic, Gracijela and Goldin, Jonathan and Aja, Ezinne and Jacobs, Jonathan P and Volkmann, Elizabeth R},
title = {International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease},
journal = {Arthritis Care & Research},
year = {2026},
doi = {10.1002/acr.25623}
}
EUVIMED